GlassScriptPhysician profile
Kimberly Gorman
NPI 1811426000
$1,309.55
in general payments reported to CMS, 2019-2025
16 companies · $453 in 2025
The $453 reported for 2025 was more than what 75% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $139 · 2022: $205 · 2023: $238 · 2024: $274 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $965.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $238.40 | 2022-2025 | Uzedy |
| Alexion Pharmaceuticals, INC. | $238.39 | 2023-2024 | Soliris, Ultomiris |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.00 | 2025 | Xifaxan |
| Lilly USA, LLC | $115.00 | 2025 | Mounjaro |
| Inari Medical, INC. | $113.46 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Daiichi Sankyo INC. | $113.40 | 2024 | Injectafer |
| Amgen INC. | $62.53 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $60.09 | 2025 | Rexulti |
| Sunovion Pharmaceuticals INC. | $50.09 | 2021 | |
| Tactile Systems Technology INC | $47.67 | 2024 | Entre Plus, Flexitouch Plus |
| Abbvie INC. | $39.53 | 2025 | |
| Eisai INC. | $30.30 | 2021 | |
| Biodelivery Sciences International, INC. | $28.85 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.37 | 2022 | |
| Kyowa Kirin, INC. | $16.19 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $13.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Gorman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.